Positive Trends and Getting a Win in HME

Published in Respiratory & Sleep on July 21, 2022

Boone LockardThis article was originally featured in HME News.  

Boone Lockard calls value-based care the “biggest ticket item” that HME providers need to buy into in the next few years.  

Value-based care has been a buzzword in healthcare for years now, but Lockard, the director of VGM Respiratory with 12 years working on both the provider and manufacturer aisles of the industry, says the COVID-19 pandemic has propelled more care into the home and, subsequently, put more pressure on providers to show they’re helping to keep patients out of hospitals.  

“I think if you can show your insurance payers that you’re keeping patients out of the ER or out of acute-care, that gives you leverage to negotiate contracts with those payers and also helps you win at the referral-source level,” he said. “If you can prove you’re not just dropping off equipment and that you have stats to back up your clinical program – that’s going to be a huge win.”  

Here’s what else Lockard, who has more than 10 years of experience in the industry on both the provider and manufacturer aisles, had to say on a recent episode of the HME News in 10 podcast, including why there’s a light at the end of the tunnel for the CPAP market, how the new NCD for oxygen will be a “big win,” and why there’s promise in resurging value-based care models. 

The recall, ‘the elephant in the room’  

“There is a light at the end of the tunnel,” he said. “The Philips device recall is one of the largest medical device recalls in history and the folks at Philips are also doing what they can to make right by this. Every step of this remediation process had to be built from the ground up and there was no playbook to get through it. They’re doing everything they can.”  

On a possible benefit of the recall: “Historically, there was ResMed and Philips in the CPAP market, and I feel like the recall has opened this up for other manufacturers to enter the space and I can see now there being a third or fourth major player in this market moving forward.”  

The mission at VGM  

“We’re here now more than ever to help providers bridge this revenue gap caused by the manufacturer crisis and exacerbated by the recall they’re working through,” he said. “My job is really to help members build or refine their ventilator or oscillating vest program. VGM is also great at connecting leaders throughout industry to talk about best practices and who’s doing what and what’s working for someone and what’s not working for someone even.”  

To listen to the podcast, go here


TAGS

  1. hme
  2. respiratory
  3. vgm

From Our Experts

Is a Global PAP Shortage Enough to Make You Diversify Your Business? thumbnail Is a Global PAP Shortage Enough to Make You Diversify Your Business? Can your business continue to weather the global PAP shortage, and if so, for how long? Are you losing referrals to other providers that can source PAP devices? Now is the time to take advantage of an emerging market: home ventilation. You don't want to miss the buck on this opportunity. Outcomes Driven by Clinical Respiratory Software and Analytics thumbnail Outcomes Driven by Clinical Respiratory Software and Analytics Patient outcomes are rapidly emerging as a powerful growth strategy. Collecting patient-focused measures and transforming that data into clinical metrics is the key to success in the respiratory DME model going forward. Why NOW is the Best Time to Get into the NIV Business thumbnail Why NOW is the Best Time to Get into the NIV Business There is currently a large opportunity in the respiratory market for non-invasive ventilation (NIV). Is your business taking advantage of this opportunity? End-Tidal CO2 (EtCO2) Monitoring in the Home thumbnail End-Tidal CO2 (EtCO2) Monitoring in the Home The End-tidal CO2 (EtCO2) test provides a non-invasive measurement of the patient's ventilation, circulation, and metabolism. Ron Hosp discusses EtCO2 and how it can benefit your company. How Investing in DME Could Save Billions of Dollars thumbnail How Investing in DME Could Save Billions of Dollars VGM and Leitten Consulting recently published an updated study, “Competitive Bidding -A Decade Focused on the Wrong Prize: The Case for Medicare Investment in DME in 2021.” The Tipping Point of Respiratory Outcomes in the Home thumbnail The Tipping Point of Respiratory Outcomes in the Home VGM's Dave Lyman talks with CEO of Encore Health Care, Zach Gantt, about the importance of respiratory outcomes in the DME world. How the Pandemic is Impacting Sleep and How a Ring Can Help Monitor Oxygen Levels thumbnail How the Pandemic is Impacting Sleep and How a Ring Can Help Monitor Oxygen Levels In this episode of Industry Matters Ronda Buhrmester, Senior Director of Payer Relations at VGM, interviews Dr. Meir Kryger, Professor of Medicine at Yale University of Medicine, about the impact COVID-19 had, and is having on sleep, as well how the BodiMetrics CIRCUL Sleep and Fitness Ring can be used to accurately track oxygen levels. The Q2 Buyer's Guide is Available Now thumbnail The Q2 Buyer's Guide is Available Now VGM & Associates is excited to announce that the second quarter Digital Buyer's Guide has been released. The latest edition can be downloaded now.